Authors:
HERBERT JM
DOL F
BERNAT A
FALOTICO R
LALE A
SAVI P
Citation: Jm. Herbert et al., THE ANTIAGGREGATING AND ANTITHROMBOTIC ACTIVITY OF CLOPIDOGREL IS POTENTIATED BY ASPIRIN IN SEVERAL EXPERIMENTAL-MODELS IN THE RABBIT, Thrombosis and haemostasis, 80(3), 1998, pp. 512-518
Authors:
HERBERT JM
BONO F
HERAULT JP
AVRIL C
DOL F
MARES AM
SCHAEFFER P
Citation: Jm. Herbert et al., EFFECTOR PROTEASE RECEPTOR-1 MEDIATES THE MITOGENIC ACTIVITY OF FACTOR XA FOR VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO AND IN-VIVO, The Journal of clinical investigation, 101(5), 1998, pp. 993-1000
Authors:
HERBERT JM
GUY AF
LAMARCHE I
MARES AM
SAVI P
DOL F
Citation: Jm. Herbert et al., INTIMAL HYPERPLASIA FOLLOWING VASCULAR INJURY IS NOT INHIBITED BY AN ANTISENSE THROMBIN RECEPTOR OLIGODEOXYNUCLEOTIDE, Journal of cellular physiology, 170(2), 1997, pp. 106-114
Authors:
SCHAEFFER P
MARES AM
DOL F
BONO F
HERBERT JM
Citation: P. Schaeffer et al., COAGULATION-FACTOR XA INDUCES ENDOTHELIUM-DEPENDENT RELAXATIONS IN RAT AORTA, Circulation research, 81(5), 1997, pp. 824-828
Citation: F. Dol et al., SIMVASTATIN INHIBITS MYOINTIMAL HYPERPLASIA FOLLOWING CAROTID-ARTERY INJURY IN CHOLESTEROL-FED RABBITS, Blood coagulation & fibrinolysis, 7(8), 1996, pp. 772-778
Authors:
HERBERT JM
BERNAT A
DOL F
HERAULT JP
CREPON B
LORMEAU JC
Citation: Jm. Herbert et al., DX-9065A, A NOVEL, SYNTHETIC, SELECTIVE AND ORALLY-ACTIVE INHIBITOR OF FACTOR XA - IN-VITRO AND IN-VIVO STUDIES, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1030-1038
Authors:
RAVANAT C
FREUND M
DOL F
CADROY Y
ROUSSI J
INCARDONA F
MAFFRAND JP
BONEU B
DROUET L
LEGRAND C
HERBERT JM
CAZENAVE JP
Citation: C. Ravanat et al., CROSS-REACTIVITY OF HUMAN MOLECULAR MARKERS FOR DETECTION OF PRETHROMBOTIC STATES IN VARIOUS ANIMAL SPECIES, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 446-455
Authors:
JUN L
ARNOUT J
VANHOVE P
DOL F
LORMEAU JC
HERBERT JM
COLLEN D
VANDEWERF F
Citation: L. Jun et al., COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN CALCIUM) ANDUNFRACTIONATED HEPARIN AS ADJUNCT TO CORONARY THROMBOLYSIS WITH ALTEPLASE AND ASPIRIN IN DOGS, Coronary artery disease, 6(3), 1995, pp. 257-263
Citation: Jm. Herbert et al., PLATELET-ACTIVATING-FACTOR (PAF) IS NOT AN ESSENTIAL COMPONENT OF THECASCADE LEADING TO SMOOTH-MUSCLE CELL-PROLIFERATION FOLLOWING VASCULAR INJURY, Journal of lipid mediators and cell signalling, 12(1), 1995, pp. 49-57
Authors:
SERRADEILLEGAL C
HERBERT JM
DELISEE C
SCHAEFFER P
RAUFASTE D
GARCIA C
DOL F
MARTY E
MAFFRAND JP
LEFUR G
Citation: C. Serradeillegal et al., EFFECT OF SR-49059, A VASOPRESSIN V-1A ANTAGONIST, ON HUMAN VASCULAR SMOOTH-MUSCLE CELLS, American journal of physiology. Heart and circulatory physiology, 37(1), 1995, pp. 404-410
Authors:
DOL F
SCHAEFFER P
LAMARCHE I
MARES AM
CHATELAIN P
HERBERT JM
Citation: F. Dol et al., EFFECT OF SR-33805 ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION FOLLOWING VASCULAR INJURY, European journal of pharmacology, 280(2), 1995, pp. 135-142
Authors:
HERBERT JM
LAMARCHE I
PRABONNAUD V
DOL F
GAUTHIER T
Citation: Jm. Herbert et al., TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS A POTENT MITOGEN FOR HUMAN AORTIC SMOOTH-MUSCLE CELLS, The Journal of biological chemistry, 269(4), 1994, pp. 3076-3080
Authors:
HERBERT JM
DELISEE C
DOL F
SCHAEFFER P
CAZAUBON C
NISATO D
CHATELAIN P
Citation: Jm. Herbert et al., EFFECT OF SR-47436, A NOVEL ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONIST,ON HUMAN VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO, European journal of pharmacology, 251(2-3), 1994, pp. 143-150
Authors:
DOL F
GAICH C
PETITOU M
BONEU B
CARANOBE C
BERNAT A
MARIE MS
HERBERT JM
Citation: F. Dol et al., THE ANTITHROMBOTIC ACTIVITY OF SYNTHETIC PENTASACCHARIDES AND FRAXIPARINE IS CLOSELY CORRELATED WITH THEIR RESPECTIVE ABILITY TO ALTER THROMBOPLASTIN-TRIGGERED THROMBIN GENERATION EX-VIVO, Thrombosis and haemostasis, 69(6), 1993, pp. 655-655
Authors:
HERBERT JM
DOL F
CAZAUBON C
DELISEE C
SCHAEFFER P
CHATELAIN P
NISATO D
Citation: Jm. Herbert et al., EFFECT OF SR-47436, A NOVEL ANGIOTENSIN-II ANTAGONIST ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION IN-VITRO, Thrombosis and haemostasis, 69(6), 1993, pp. 802-802
Authors:
HERBERT JM
SAVI P
LAPLACE MC
DUMAS A
DOL F
Citation: Jm. Herbert et al., CHELERYTHRINE, A SELECTIVE PROTEIN-KINASE-C INHIBITOR, COUNTERACTS PYROGEN-INDUCED EXPRESSION OF TISSUE FACTOR WITHOUT EFFECT ON THROMBOMODULIN DOWN-REGULATION IN ENDOTHELIAL-CELLS, Thrombosis research, 71(6), 1993, pp. 487-493
Citation: P. Savi et al., ADP-DEPENDENCE OF PLATELET ACTIVATION-INDUCED BY A THROMBIN RECEPTOR AGONIST, Nouvelle revue francaise d'hematologie, 35(2), 1993, pp. 115-119
Authors:
HERBERT JM
SAVI P
LAPLACE MC
LALE A
DOL F
DUMAS A
LABIT C
MINTY A
Citation: Jm. Herbert et al., IL-4 AND IL-13 EXHIBIT COMPARABLE ABILITIES TO REDUCE PYROGEN-INDUCEDEXPRESSION OF PROCOAGULANT ACTIVITY IN ENDOTHELIAL-CELLS AND MONOCYTES, FEBS letters, 328(3), 1993, pp. 268-270